Brain-Derived Extracellular Vesicles from Dahl Salt-Sensitive Rats with High Salt Diet Increase PVN and SON Vasopressin Levels in Sprague Dawley rats
Authors: Chen Xinqian , Yan Xin , Bi Lanrong , Chen Qinghui , Shan Zhiying 
Published: May 2024

Extracellular vesicles (EVs), naturally secreted by almost all cell types, encapsulate a broad spectrum of biological molecules, and ferry these contents to the local and distal recipient cells. Under disease conditions, EV-to-cell communication can lead to diverse cell responses and changes. Previously we have demonstrated that brain-derived EVs from hypertensive rats increased inflammation and oxidative stress in primary neurons and hypothalamic paraventricular nucleus (PVN) of the brain, however, the long-term effects of EVs are unclear. PVN is a key hub to mediate blood pressure via its endocrine and autonomic control. Increased vasopressin (AVP) levels have been found in Dahl salt sensitive hypertensive rats, which are produced by PVN and supraoptic nucleus (SON). In this study, we hypothesized that brain-derived EVs from hypertensive rats regulate blood pressure via AVP system. To test this hypothesis, we first labeled brain-derived EVs with Rhodamine dye (Rho-EVs) and studied their bio-distribution via intracerebroventricular (i.c.v.) injection into the normal Sprague Dawley (SD) rats. Rats were euthanized 24 hours after injection, and brain sections containing the PVN and SON regions were stained to test the colocalization of Rho-EVs with neurons (NeuN), astrocytes (GFAP) and microglia (Iba1). Then we injected brain-derived EVs obtained from hypertensive Dahl salt sensitive rats (DSS-EVs) and normotensive Sprague Dawley rats (SD-EVs) into the lateral ventricle (8 μg/rat) in the SD male rats, and the injection was repeated 2 weeks later. Blood pressure and heart rates of each rat were monitored each week using telemetry transducers. 4 weeks post first EVs injections, rats were euthanized, their blood were tested for plasma AVP and norepinephrine (NE) levels, and their brains were tested for AVP and Fos-related antigen 1 (Fra1) mRNA levels. Besides, we also performed biweekly PVN (800 ng/rat) and SON (800ng/rat) injections of DSS-EVs and SD-EVs and measured the AVP and/or Fra1 protein levels with immunostaining. Lastly, we determined the colocalization of Rho-EVs with AVP-containing cells in the PVN and SON. Results show that Rho-EVs are dominantly taken up by neurons in both PVN and SON regions. Biweekly i.c.v. injections of DSS-EVs do not increase blood pressure and heart rate. However, DSS-EVs significantly upregulate mRNA levels of AVP (2.4-fold) and Fra1 (2.5-fold) in the PVN compared to SD-EVs. There is an increasing trend of plasma AVP levels in DSS-EV-treated rats compared to control. Biweekly PVN injections of DSS-EVs significantly increase AVP (1.5-fold) protein levels relative to SD-EVs, and biweekly SON injections of DSS-EVs significantly increase AVP (1.5-fold) and Fra1 (2.6-fold) protein levels relative to SD-EVs. Lastly, we found that Rho-EVs are mainly colocalized with vasopressin-containing cells in the SON. These results suggest that brain-derived EVs cause SON and PVN neuron activation, which in turn may regulate AVP system during hypertensive development.

R01HL163159 (Shan); R15HL150703 (Shan); AHA 1807047 (Bi).

This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.